Accès à distance ? S'identifier sur le proxy UCLouvain
Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy.
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2017 |
Language | Anglais |
Journal information | "International Journal of Pharmaceutics" - Vol. 524, no. 1-2, p. 159-167 (2017) |
Peer reviewed | yes |
Publisher | Elsevier/North-Holland Biomedical Press ((Netherlands) Amsterdam) |
issn | 0378-5173 |
e-issn | 1873-3476 |
Publication status | Publié |
Affiliations |
UCL
- SSS/LDRI - Louvain Drug Research Institute UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology UCL - (SLuc) Service de biochimie médicale |
Links |
Bibliographic reference | Guichard, Marie-Julie ; Patil, Harshad Padmanabh ; Koussoroplis, Salome Juliette ; Wattiez, Ruddy ; Leal, Teresinha ; et. al. Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy.. In: International Journal of Pharmaceutics, Vol. 524, no. 1-2, p. 159-167 (2017) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/184010 |